☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
test
Share this
PS Admin
May 7, 2024
Magazine
test
dfdfgsdgsdg
Click here
to read the full press release
Comments
Fill this Details
×
Name
Email
Company Name
Thank you for download PDF
Submit
Related News/Articles
Regulatory
The US FDA Rejects Dynavax’ Four-Dose Heplisav-B Regimen for Adults on Hemodialysis
May 15, 2024
Pharma
Dynavax Reports Preclinical Study Publication of TLR9 Agonist for Treatment of Lung Cancer
September 5, 2018
Regulatory
Moderna Receives Health Canada Authorization for Updated COVID-19 Vaccine SPIKEVAX XBB.1.5
September 13, 2023
Viewpoints
PharmaShots Interview: Medicago’s Brian Ward Shares Insights on COVIFENZ, a Plant-Based COVID-19 Vaccine
May 25, 2022
COVID-19
Regulatory
Pfizer and BioNTech Seek the US FDA’s EUA for Booster Dose of their COVID-19 Vaccine in Children Aged 5 Through 11 Years
April 27, 2022
Viewpoints
PharmaShots Interview: Medicago’s Brian Ward Shares Insights on the Data of Plant-Based COVID-19 Vaccine
January 12, 2022
COVID-19
GSK and Medicago Reports Results of COVID-19 Vaccine in P-III Study for the Treatment of COVID-19
December 8, 2021
Clinical Trials
Clover Initiates P-II Trial of COVID-19 Vaccine as Heterologous Booster for the Treatment of COVID-19
November 29, 2021
COVID-19
Clinical Trials
Moderna Reports Results of COVID-19 Vaccine in P-II/III KidCOVE Study for the Treatment of COVID-19
October 26, 2021
Regulatory
Johnson & Johnson Reports EUA Submission to the US FDA for Supporting the Booster of its Single Shot COVID-19 Vaccine Candidate
October 6, 2021
Liked our insights or summarized news?
Subscribe to our Daily/Weekly newsletter
×
First Name
Last Name
Daily Newsletter
Weekly Newsletter
I agree to the privacy policy and terms.(
Link
)
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions
X
Liked our insights or summarized news?
Subscribe to our Daily/Weekly newsletter
Subscribe
